InvestorsHub Logo
icon url

Jesspro

09/16/11 9:43 AM

#12613 RE: ariadndndough #12611


Dough, are there any current drugs in the market today for sarcoma that are better or touted to be better than the P3 data of RIDA? If none, I think you're right that RIDA will rule for sometime in this market until a new one comes along and I don't hear any biotech or pharma that has one in the clinical trial that is making a splash.